Medication‐induced mood disorders following epidural steroid injections in patients with pain: A case series

KEY CLINICAL MESSAGE: Medication‐induced mood disorders following epidural steroid injections are possible therefore should be disclosed to the patient. ABSTRACT: Medication‐induced mood disorders have been rarely reported following epidural steroid injections (ESI). This case series presents three...

Descripción completa

Detalles Bibliográficos
Autores principales: Vangeison, Christian T., Roys, Joseph P., Catalanotto, Marissa N., Kupperman, Wyatt I., Kovacs, Alexander R., Dîrzu, Dan Sebastian, Husu, Emanuel N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10213705/
https://www.ncbi.nlm.nih.gov/pubmed/37251746
http://dx.doi.org/10.1002/ccr3.7415
Descripción
Sumario:KEY CLINICAL MESSAGE: Medication‐induced mood disorders following epidural steroid injections are possible therefore should be disclosed to the patient. ABSTRACT: Medication‐induced mood disorders have been rarely reported following epidural steroid injections (ESI). This case series presents three patients who met the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM‐5) criteria for substance/medication‐induced mood disorder after an ESI. In considering a candidacy for ESI, the rare but significant, side effects of psychiatric side effects should be disclosed to patients.

Ejemplares similares